Gyre Therapeutics, Inc. (GYRE)
NASDAQ·Healthcare·Biotechnology
$5.66
-5.51%
Mkt Cap $549.26M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$17.00
Range $16.00 – $18.00
Implied Upside
+200.4%
Consensus $17.00 vs current $5.66
NASDAQ·Healthcare·Biotechnology
$5.66
-5.51%
Mkt Cap $549.26M
No recent rating data.
Price Target (2 analysts)
$17.00
Range $16.00 – $18.00
+200.4%
Consensus $17.00 vs current $5.66